NRC Health Common Stock
NRC
103 hedge funds and large institutions have $654M invested in NRC Health Common Stock in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 8 closing their positions.
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
14% more capital invested
Capital invested by funds: $571M → $654M (+$82.5M)
12% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 33
7% more funds holding
Funds holding: 96 → 103 (+7)
0.01% more ownership
Funds ownership: 39.75% → 39.76% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.48M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.47M |
| 3 |
Neuberger Berman Group
New York
|
+$1.75M |
| 4 |
Renaissance Technologies
New York
|
+$1.47M |
| 5 |
Daiwa Securities Group
Tokyo,
Japan
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.6M |
| 2 |
RA
Royce & Associates
New York
|
-$2.34M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$1.71M |
| 4 |
Bank of New York Mellon
New York
|
-$1.26M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$663K |
NRC Hedge Fund Activity: Q4 2019 in Review
103 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q4 2019, worth a combined $654M — up 14% from $571M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NRC positions and 8 closed out — a net gain of 8 holders — while 37 added to existing stakes and 33 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.48M. The largest seller was Ameriprise, cutting an estimated $4.6M.
- 103 institutional investors held NRC Health Common Stock (NRC) as of Q4 2019, up from 96 in Q3 2019.
- Funds reported $654M of NRC Health Common Stock stock for Q4 2019, up 14% quarter-over-quarter.
- 16 funds opened new NRC Health Common Stock positions in Q4 2019 and 8 closed out, a net change of +8 holders.
- The largest NRC Health Common Stock buyer in Q4 2019 was Vanguard Group, an estimated $3.48M added.
- The largest NRC Health Common Stock seller in Q4 2019 was Ameriprise, an estimated $4.6M sold.
Based on aggregated 13F filings for Q4 2019.